FDA updates on hand sanitizers safety for use
The U.S. Food and Drug Administration (FDA) has announced that it is providing a new laboratory testing method to assess the quality of finished hand sanitizers. Moreover, the FDA has issued a new press release on August 27th 2020, where it warns consumers about hand sanitizers packaged in food and drink containers. Earlier this month, the FDA expanded hand sanitizer warnings to include 1-propanol contamination.

FDA’s TESTING METHOD FOR HAND SANITIZERS

The Food and Drug Administration (FDA) regulates hand sanitizers in the U.S., as they are considered over-the-counter (OTC) drugs. Recently, the FDA warned consumers about methanol contamination in some hand sanitizers (and consequences of its use), publishing a list of hand sanitizers that have tested positive for methanol and advising consumers not to use it. Additionally, the FDA issued updated guidance to provide additional clarification on testing of alcohol used in hand sanitizers manufactured under FDA’s temporary policies. The guidance recommended test methods (USP monograph for ethanol) as well as conducting the testing in a laboratory previously inspected by the FDA and in compliance with current good manufacturing practice (cGMP). The main goal of these guidelines was to help ensure that harmful levels of methanol were not present and that such hand sanitizers are free from contamination. Under the FD&C Act, alcohol-based hand sanitizers that are contaminated with methanol are subject to adulteration charges.

On August 24th 2020, to help ensure that hand sanitizers contain the correct ingredients and do not contain harmful levels of impurities, the FDA provided a laboratory testing method. A Gas Chromatography-Mass Spectromatry (GC-MS) method was developed and validated for the quality assessment of hand sanitizers. This method can be used to test the quantity of alcohol (ethanol and isopropanol) as well as detect impurities (listed in the FDA hand sanitizer guidance).

The United States Pharmacopeia (USP) revision bulletin for alcohol and dehydrated alcohol monographs include testing ethanol for methanol contamination as a quality standard and it will be official from September 1st 2020.

FDA’s UPDATE ON HAND SANITIZERS CONTAMINATION AND PACKAGING

Two days ago, FDA issued a new press release, warning consumers about alcohol-based hand sanitizers that are being packaged in containers that may appear as food or drinks and which, if ingested, may put consumers at risk of serious injury or death.

The FDA has found hand sanitizers packaged in beer cans, children’s food pouches, water bottles, juice bottles and vodka bottles and it has also found that some hand sanitizers contain food flavours (e.g. chocolate or raspberry). One of the reports received by the FDA described a consumer that purchased a bottle thinking it was a drinking water when it actually was a hand sanitizer. This kind of products may result in consumer’s confusion and lead to incidental ingestion of hand sanitizers. Hand sanitizers can be toxic when ingested and there has been increasing reports of adverse effects following hand sanitizer ingestion.

The overall goal of the FDA updates and press releases is to protect health care providers and consumers from using dangerous hand sanitizer products. The increasing people’s awareness to problems associated with hand sanitizers – contamination and misuse – is an essential route to avoid adverse effects and ensure the correct use of such products.

References:

U.S. Food and Drug Administration (FDA) – FDA Updates on Hand Sanitizers Consumers Should not Use. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-hand-sanitizers-consumers-should-not-use

U.S. Food and Drug Administration (FDA) – Direct Injection Gas Chromatography Mass Spectrometry (GC-MS) Method for the Detection of Listed Impurities in Hand Sanitizers. Available at: https://www.fda.gov/media/141501/download

United States Pharmacopeia (USP) – Alcohol Revision Bulletin. Available at: https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/revisions/alcohol-rb-notice-20200817.pdf

U.S. Food and Drug Administration (FDA) – FDA New Release – COVID-19 Update: FDA Warns Consumers About Hand Sanitizer Packaged in Food and Drink Containers. Available at: https://www.fda.gov/news-events/press-announcements/covid-19-update-fda-warns-consumers-about-hand-sanitizer-packaged-food-and-drink-containers

further
reading

news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »
medical devices

Amendments to the Transitional Provisions of the European Union MDR and IVDR

The proposed amendments aim to maintain patients’ access to a wide range of medical devices while ensuring the transition to the new framework. The ammendments proposal aims to extend the current transition period (Article 120 of the MDR), and it also deletes the ‘sell-off’ deadlines of both MDR and IVDR. The extension is staggered depending on the risk class of the device – until December 2027 for high-risk devices and December 2028 for medium and lower-risk devices.

Read More »
medical devices

EU MDR – Proposal for Extension of Transition Period

The transition to MDR has been slower than anticipated by the European Commission. Insufficient capacity of notified bodies and the low level of preparedness of manufacturers led to a proposal for extension of current MDR transition period with deadlines depending on the risk class of the devices.

Read More »
medical devices

MDCG 2022-18 – EU MDR Article 97

EU MDR Article 97 may be a temporary solution to avoid disruption of supply of Medical Devices on the EU Market. The MDCG 2022-18 presents a uniform approach for application of MDR Article 97 on non-compliant legacy devices under the conditions set by the competent authorities, while limiting the impact on the supply of safe and effective devices.

Read More »